Injective falls 8.09% as price struggles to stay above $4.75 support

Injective falls 8.09% as price struggles to stay above $4.75 support
Injective drops 8.09% today to $4.90

Injective (INJ) is trading at $4.90, down 8.09% for the session. The asset remains above its key moving averages, despite notable intraday weakness.

INJ price prediction
24H 5.54%
$5.33
48H 5.15%
$5.31
7D -4.36%
$4.83
1M 39.6%
$7.05
3M 235.25%
$16.93
6M 191.88%
$14.74
12M 163.96%
$13.33
Current price: $ 5.05 -0.27 5.00%
Real-time Data 15:16
Daily range 5 Arrow from to Icon 5.29
Weekly range 4.89 Arrow from to Icon 5.93
Loading...

Highlights

  • INJ's price remains in a broader bullish technical structure, holding above short-, medium-, and long-term trend indicators.
  • Despite ongoing positive momentum, intraday action diverges with an 8% drop and increased volatility, pointing to near-term risk.
  • Forecast for the next five sessions expects ranging between $4.75 and $5.40, with downside favored if $4.75 support breaks.

Bullish signals clash with overbought warnings amid volatility

The INJ price sits above specific key technical levels, with support from the SMA-20 at $4.55, SMA-50 at $3.76, and SMA-200 at $4.30. The Ichimoku Kijun level at $4.75 provides immediate technical support just below the market. On the daily timeframe, MACD and ADX readings point to continued bullish momentum, while CCI and Bull/Bear Power signal overbought conditions. RSI stands near the overbought threshold at 67.64, with Stoch RSI in a neutral position. The Awesome Oscillator also affirms underlying positive momentum, but today's deeper sell-off and high volatility highlight a divergence between daily oscillator signals and current price action.

Injective asset chart
Injective price dynamics. Source: TradingView.

Downside risks rise as breakout odds remain limited

Over the next five trading days, INJ is expected to fluctuate within a band of $4.75 to $5.40, reflecting typical volatility near present levels. The probability of a sustained breakout above $5.40 remains below 20%, which makes a further decline more likely in the short term. The base case anticipates sideways stabilization, while a bullish scenario requires a decisive push above $5.40 and a bearish extension could be triggered if support at $4.75 fails.

Viktoras Karapetjanc, expert at Traders Union, notes that INJ holds above key supports despite today's volatile decline. He observes continued bullish momentum in technical indicators, with overbought signals tempering immediate upside potential. The analyst sees a higher chance of sideways action than a breakout, but remains constructive as long as support holds. "If INJ stays above $4.75, I expect buyers to defend this level and keep the bull case alive in the short term."

Earlier, analysts noted that Injective was demonstrating strong bullish momentum supported by positive technical indicators and institutional participation. The current session's notable sell-off and increased volatility signal emerging downside risk, making the $4.75 support level a critical threshold to monitor for a potential shift in market direction.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.